There were 1,822 press releases posted in the last 24 hours and 439,467 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image